Literature DB >> 16010751

Cholera in Mozambique, variant of Vibrio cholerae.

M Ansaruzzaman, N A Bhuiyan, Balakrish G Nair, David A Sack, Marcelino Lucas, Jacqueline L Deen, Julia Ampuero, Claire-Lise Chaignat.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16010751      PMCID: PMC3329043          DOI: 10.3201/eid1011.040682

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Cholera outbreaks caused by toxigenic Vibrio cholerae serogroup O1 frequently occur in many sub-Saharan African countries. The serogroup O1 is classified into two biotypes, classical and El Tor. The seventh and current pandemic of cholera is caused by the El Tor biotype; the classical biotype is believed to be extinct. The classical and El Tor biotypes of V. cholerae O1 are closely related in their O-antigen biosynthetic genes but differ in other regions of the genome. The genomic structure of the CTXΦ filamentous phage (), in which the cholera toxin genes are contained, differs between the classical and El Tor biotypes. CTXclassΦ is found in classical strains, CTXETΦ is present in El Tor and O139 strains, and CTXcalcΦ is found in resurgent O139 strains. The diversity of CTXΦ among biotypes is mainly due to the variations in the repeat sequence elements, particularly in the rstR gene region (). While conducting surveillance in the cholera treatment center in Beira, the second largest city in Mozambique, we examined 175 rectal swabs or stool samples from January 7 to March 8, 2004, using standard published procedures. During this period, we isolated 58 strains of V. cholerae O1. The isolates were transported to the Enteric Microbiology Unit of the International Center for Diarrhoeal Disease Research in Dhaka, Bangladesh (ICDDRD,B), for further phenotypic and genotypic characterization to determine serotype, biotype, and presence of important virulence genes. All 58 strains were identified as V. cholerae O1 of the Ogawa serotype. Forty strains selected for detailed characterization were resistant to polymyxin B, agglutinated chicken cells, yielded a positive Voges-Proskauer reaction, were positive for the El Tor hemolysin by the tube agglutination method, and were sensitive to group IV El Tor phage but resistant to the classical group V phage and were therefore classified as the El Tor biotype. The antimicrobial susceptibility of 15 of the 40 isolates examined showed that the strains were sensitive to tetracycline, ampicillin, furazolidone, erythromycin, and ciprofloxacin but resistant to trimethoprim-sulfamethoxazole, and also to the vibriostatic compound 0/129. By using polymerase chain reaction (PCR), we established that all 40 strains carried the ctxA gene (constituent gene of the CTX prophage) and the tcpA gene (the El Tor type), a constituent gene of the vibrio pathogenicity island. We then focused on the rstR gene because of its diversity between the two biotypes. All of the 40 El Tor strains produced a 500-bp PCR product of the rstR gene of the classical type (rstRclass), despite belonging to the El Tor biotype. Nucleotide sequence analysis of the rstR gene of two representative Mozambique strains showed 100% homology to the classical rstR gene of classical reference strain O395. The amino acid sequence of the B-subunit of classical and El Tor biotypes have distinct signature sequences (). We amplified the ctxB gene using specific primers and found that the deduced amino acid sequence of the CT-B subunit of the Mozambique strains varied from the El Tor CT-B subunit at positions 39 (histidine replaces tyrosine in El Tor) and 68 (threonine replaces isoleucine in El Tor), and the amino acid residues at these positions are identical to those of the classical CT-B subunit (Figure). The nucleotide sequences obtained for ctxB of the two Mozambique strains B33 and B65 were deposited in GenBank under accession no. AY648939 and AY6448940, respectively. Therefore, the Mozambique strains of V. cholerae O1 displayed typical traits of the El Tor biotype overall but carried the classical CTX prophage.
Figure

Amino acid sequence alignment of CT-B subunit of Vibrio cholerae O1 classical, El Tor, and Mozambique (B33 and B65) strains. Identical amino acid residues are indicated by a period. Amino acid sequences of CtxB of V. cholerae classical (AAL60524.1; AAM47189.1) and El Tor (AAM74192.1; AAM77066.1) are from GenBank.

Amino acid sequence alignment of CT-B subunit of Vibrio cholerae O1 classical, El Tor, and Mozambique (B33 and B65) strains. Identical amino acid residues are indicated by a period. Amino acid sequences of CtxB of V. cholerae classical (AAL60524.1; AAM47189.1) and El Tor (AAM74192.1; AAM77066.1) are from GenBank. Our findings that El Tor strains of V. cholerae O1 from Mozambique are carrying the classical prophage shows the presence of genetic materials associated with the classical biotype in Mozambique. Further, these findings provide the first circumstantial evidence of transmission of the classical CTX prophage. The CTX prophages in El Tor strains give rise to infectious phage particles (1), but neither of the two CTX prophages integrated at two different sites of the classical genome give rise to phage particles (). Subsequent studies have shown that, although the genes of the classical prophages encode functional forms of all of the proteins needed for production of CTXΦ, the CTX prophage does not yield virions because of the atypical arrangement of its prophage arrays (). Genetic hybrids between El Tor and classical biotypes of O1 V. cholerae were reported among sporadic isolates earlier in Bangladesh () and were named the Matlab variants after the place where they were first isolated. The Mozambique strains of V. cholerae likely evolved from an El Tor strain, which shed its CTX phage and acquired the classical prophage. Alternatively, strains like the Matlab variant may have spread to the African subcontinent. Whether introducing the CTX prophage in the El Tor genome background will increase pathogenicity, affect genomic stability, or enhance the epidemic-causing potential is uncertain. This subtle genetic change might also alter the effectiveness of current cholera vaccines which stimulate antitoxic as well as antibacterial immunity.
  4 in total

1.  Lysogenic conversion by a filamentous phage encoding cholera toxin.

Authors:  M K Waldor; J J Mekalanos
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

2.  Diverse CTXphis and evolution of new pathogenic Vibrio cholerae.

Authors:  H H Kimsey; G B Nair; A Ghosh; M K Waldor
Journal:  Lancet       Date:  1998-08-08       Impact factor: 79.321

Review 3.  Filamentous phages linked to virulence of Vibrio cholerae.

Authors:  Brigid M Davis; Matthew K Waldor
Journal:  Curr Opin Microbiol       Date:  2003-02       Impact factor: 7.934

4.  New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh.

Authors:  G Balakrish Nair; Shah M Faruque; N A Bhuiyan; M Kamruzzaman; A K Siddique; David A Sack
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

  4 in total
  67 in total

1.  Development and evaluation of a PCR assay for tracking the emergence and dissemination of Haitian variant ctxB in Vibrio cholerae O1 strains isolated from Kolkata, India.

Authors:  Arindam Naha; G P Pazhani; Mou Ganguly; Santanu Ghosh; T Ramamurthy; Ranjan K Nandy; G Balakrish Nair; Yoshifumi Takeda; Asish K Mukhopadhyay
Journal:  J Clin Microbiol       Date:  2012-02-22       Impact factor: 5.948

Review 2.  New-generation vaccines against cholera.

Authors:  John Clemens; Sunheang Shin; Dipika Sur; G Balakrish Nair; Jan Holmgren
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-08       Impact factor: 46.802

3.  Cholera toxin production by the El Tor variant of Vibrio cholerae O1 compared to prototype El Tor and classical biotypes.

Authors:  J Ghosh-Banerjee; M Senoh; T Takahashi; T Hamabata; S Barman; H Koley; A K Mukhopadhyay; T Ramamurthy; S Chatterjee; M Asakura; S Yamasaki; G B Nair; Y Takeda
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

4.  Cholera in India: an analysis of reports, 1997-2006.

Authors:  S Kanungo; B K Sah; A L Lopez; J S Sung; A M Paisley; D Sur; J D Clemens; G Balakrish Nair
Journal:  Bull World Health Organ       Date:  2010-03       Impact factor: 9.408

5.  A cholera outbreak of the Vibrio cholerae O1 El Tor variant carrying classical CtxB in northeastern Thailand in 2007.

Authors:  Kazuhisa Okada; Siriporn Chantaroj; Amonrattana Roobthaisong; Shigeyuki Hamada; Pathom Sawanpanyalert
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

6.  Genomic relatedness of the new Matlab variants of Vibrio cholerae O1 to the classical and El Tor biotypes as determined by pulsed-field gel electrophoresis.

Authors:  Ashrafus Safa; Nurul Amin Bhuiyan; Munirul Alam; David A Sack; G Balakrish Nair
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

7.  Microarray-based detection of genetic heterogeneity, antimicrobial resistance, and the viable but nonculturable state in human pathogenic Vibrio spp.

Authors:  Gary J Vora; Carolyn E Meador; Michele M Bird; Cheryl A Bopp; Joanne D Andreadis; David A Stenger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-14       Impact factor: 11.205

8.  Spread of cholera with newer clones of Vibrio cholerae O1 El Tor, serotype inaba, in India.

Authors:  B Dutta; R Ghosh; N C Sharma; G P Pazhani; N Taneja; A Raychowdhuri; B L Sarkar; S K Mondal; A K Mukhopadhyay; R K Nandy; M K Bhattacharya; S K Bhattacharya; T Ramamurthy
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

Review 9.  Global dissemination of Vibrio parahaemolyticus serotype O3:K6 and its serovariants.

Authors:  G Balakrish Nair; Thandavarayan Ramamurthy; Sujit K Bhattacharya; Basabjit Dutta; Yoshifumi Takeda; David A Sack
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

10.  RS1 satellite phage promotes diversity of toxigenic Vibrio cholerae by driving CTX prophage loss and elimination of lysogenic immunity.

Authors:  M Kamruzzaman; William Paul Robins; S M Nayeemul Bari; Shamsun Nahar; John J Mekalanos; Shah M Faruque
Journal:  Infect Immun       Date:  2014-06-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.